AIBOTICS, INC.
AIBOTICS, INC.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | |||||||||||||||||
Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Receivables | - | - | 0 | - | - | - | - | - | - | - | - | - | |||||
Prepaid Expense Current | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | - | - | - | |||||
Inventory Net | 0 | - | - | - | - | - | - | - | - | - | - | - | |||||
Fixtures And Equipment Gross | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Assets Noncurrent | |||||||||||||||||
Property Plant And Equipment Net | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Intangible Assets Net Including Goodwill | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | - | - | |||||
Assets | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 0 | 0 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Accounts Payable And Accrued Liabilities Current | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||||
Liabilities Current | |||||||||||||||||
Accrued Liabilities And Other Liabilities | - | - | - | - | - | - | - | - | - | - | 1 | - | |||||
Liabilities Current | - | - | - | - | - | - | - | - | - | 4 | 2 | 2 | |||||
Convertible Debt Current | - | - | - | - | - | - | - | - | - | - | 1 | - | |||||
Accrued Liabilities Current | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Convertible Notes Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | 1 | |||||
Convertible Debt | - | - | - | - | - | - | - | - | - | 0 | - | 0 | |||||
Liabilities | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 2 | 2 | |||||
Temporary Equity | |||||||||||||||||
Temporary Equity Carrying Amount Attributable To P… | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Stockholders Equity | -4 | -4 | -4 | -4 | -4 | -3 | -3 | -3 | -2 | -2 | -2 | -1 | |||||
Common Stock Value | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 9 | 9 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | |||||
Retained Earnings Accumulated Deficit | -13 | -13 | -12 | -12 | -11 | -11 | -10 | -10 | -9 | -9 | -9 | -8 | |||||
Liabilities And Stockholders Equity | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 0 | 0 | |||||
Convertible Debt Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | - | |||||
Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | - | - | 0.001 | 0.001 | 0 | 0.001 | 0.001 | |||||
Temporary Equity Shares Authorized | - | - | - | - | - | - | - | 5 | 5 | 5 | 5 | 5 | |||||
Temporary Equity Shares Outstanding | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Series B Preferred Stock | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Series A Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | - | - | 5 | - | - | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0 | 0.001 | 0.001 | 0.001 | 0 | 0.001 | 0.001 | 0.001 | 0 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 7,500 | 7,500 | 467 | 467 | 7,500 | 467 | 467 | 500 | 500 | 500 | 500 | 500 | |||||
Common Stock Shares Issued | 539 | 487 | 319 | 310 | 317 | 320 | 345 | 358 | 358 | 358 | 358 | 358 | |||||
Shares Outstanding | 539 | 487 | 319 | 310 | 317 | 320 | 345 | 358 | 358 | 358 | 358 | 358 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.00% | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | -15.38% | -23.08% | -76.92% | 0.00% | 33.33% | -33.33% | 50.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 2024 | -25.00% | -37.50% | -47.92% | 3.45% | -20.69% | -10.34% | -31.58% | -15.79% | 57.89% | 22.22% | 0.00% | -33.33% |
| 2023 | 4.55% | 36.36% | 9.09% | 125.00% | 0.00% | -37.50% | 66.67% | -46.67% | -33.33% | -31.03% | -31.03% | -48.28% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | - | - | - | - | - | - | - | - | - | 0.07 | 0.15 | 0.19 | |||||
| Quick Ratio | - | - | - | - | - | - | - | - | - | 0.07 | 0.15 | 0.19 | |||||
| Working Capital | - | - | - | - | - | - | - | - | - | -3.97M | -1.74M | -1.43M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | - | - | - | - | - | - | - | - | - | -2.09 | -1.18 | -1.24 | |||||
| Interest Coverage TTM | -7.49 | -8.13 | -12.54 | -8.34 | -8.13 | -7.27 | -4.13 | -2.84 | -1.77 | -1.09 | -1.08 | -0.94 | |||||
| Debt Ratio | - | - | - | - | - | - | - | - | - | 1.91 | 6.47 | 5.20 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Free Cash Flow Per Share TTM | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Operating Profit Margin TTM | - | -84,501.74% | -85,555.93% | -81,199.18% | -82,611.50% | - | - | - | - | - | - | - | |||||
| Net Profit Margin TTM | - | -0.00% | -11,484.48% | -8,288.10% | -7,579.26% | - | - | - | - | - | - | - | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -100.00% | - | - | - | - | - | - | - | - | - | - | - | |||||
| Net Income Growth (1Y) | -204.74% | -92.86% | -84.78% | -87.91% | -87.31% | -100.00% | 10.29% | 1.24% | -19.00% | -54.77% | -67.84% | -78.07% | |||||
| EPS Growth (1Y) | -161.50% | -95.31% | -83.52% | -86.04% | -85.68% | -100.00% | 14.18% | 1.24% | -19.21% | -54.89% | -68.58% | -78.74% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 3.11 | -146,068,608.83 | -6.36 | -15.41 | -111.02 | -38,848,307.91 | -5.45 | -7.17 | -32.89 | -4.84 | -5.74 | -8.23 | |||||
| P/B TTM | -0.13 | -0.37 | -0.41 | -0.66 | -4.79 | -1.60 | -2.67 | -3.67 | -17.48 | -2.82 | -4.94 | -8.51 | |||||
| P/S TTM | - | 669.12 | 730.40 | 1,277.03 | 8,414.62 | - | - | - | - | - | - | - | |||||
| Market Cap | 539.37K | 1.46M | 1.59M | 2.79M | 18.37M | 5.44M | 8.98M | 10.73M | 42.90M | 5.72M | 8.58M | 12.16M | |||||
| Enterprise Value | 1.44M | 2.32M | 2.68M | 3.90M | 19.31M | 6.35M | 9.88M | 11.55M | 43.63M | 6.53M | 9.31M | 12.74M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -466.14K | -458.24K | -388.90K | -287.73K | -213.69K | -259.04K | -279.63K | -223.99K | -151.60K | -106.77K | -117.87K | -440.91K | |||||
| Net Debt | 904.16K | 862.33K | 1.08M | 1.11M | 943.26K | 914.90K | 897.64K | 820.10K | 729.58K | 811.52K | 724.57K | 589.00K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
AIBOTICS, INC. (AIBT) — SEC Financial Statements & Analysis
AIBOTICS, INC. (AIBT) is a medicinal chemicals & botanical products company, incorporated in NV. AIBOTICS, INC. trades on OTC as: AIBT. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), AIBOTICS, INC. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of -2.09x, a Price-to-Sales (P/S) ratio of 669.12x (TTM), a Price-to-Book (P/B) ratio of -0.13 (TTM), at a market cap of $539.37K. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -100.00%
- Debt To Equity
- -2.09x
- P/S TTM
- 669.12x
- P/B TTM
- -0.13
- Market Cap
- $539.37K
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is AIBOTICS, INC. in?
AIBOTICS, INC. (AIBT) operates in the Medicinal Chemicals & Botanical Products industry.
What is AIBT's market cap?
AIBOTICS, INC. (AIBT) has a market capitalization of $539.37K as of 2026-03-31.
What is AIBT's P/E ratio?
AIBOTICS, INC. (AIBT)'s trailing twelve month P/E ratio is 3.11x as of 2026-03-31.
What exchange does AIBT trade on?
AIBOTICS, INC. (AIBT) trades on the OTC.
Where is AIBOTICS, INC. incorporated?
AIBOTICS, INC. is incorporated in NV.